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SYNOPSIS 
Objectives. We described young women in North Carolina (NC) who were 
pregnant at the time of diagnosis with human immunodeficiency virus (HIV) 
infection to identify an at-risk population that could be targeted for increased 
HIV screening. We investigated the combined effect of partner counseling and 
referral services (PCRS) and comprehensive prenatal HIV screening.
Methods. We conducted a retrospective review of PCRS charts on young 
women newly diagnosed with HIV in NC between 2002 and 2005. We 
determined the prevalence of pregnancy in the study sample and conducted 
bivariate analyses to assess predictors of pregnancy at the time of HIV diagno-
sis, calculating prevalence ratios (PRs) with 95% confidence intervals (CIs). We 
analyzed results of partner notification efforts, including timing and stage of 
diagnosis of HIV-positive partners.
Results. During the four-year period, 551 women aged 18–30 years were newly 
diagnosed with HIV; 30% were pregnant at the time of HIV diagnosis. Pregnant 
women were more likely to be Hispanic (PR51.58, 95% CI 1.15, 2.17) and not 
report typical risk factors. Fourteen percent of pregnant women’s partners had 
an undiagnosed infection compared with slightly more than 8% of nonpregnant 
women’s partners (p,0.01). 
Conclusions. Ethnic differences in co-diagnosis of pregnancy and HIV suggest 
that young Hispanic women may have differential access to and acceptance 
of routine HIV screening. Comprehensive prenatal screening combined with 
partner notification can be effective in reaching infected male partners who are 
undiagnosed.
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Many women in the United States are not routinely 
tested for human immunodeficiency virus (HIV).1 
Health-care providers may not offer HIV tests due to 
policies (e.g., inadequate reimbursement) or logistics 
(e.g., time constraints)2 and, prior to 2006, recom-
mendations of risk-based screening.3 Women may 
not request and/or accept tests due to fear of testing 
positive or a low perception of risk,4,5 particularly 
women who are in relationships.6 Routine testing dur-
ing prenatal care increases testing opportunities for 
women. In the 2006 National Health Interview Survey, 
more than 60% of women who were pregnant at the 
time of the interview reported an HIV test in the last 
year compared with less than 13% of all nonpregnant 
women.1 Women who are diagnosed with HIV dur-
ing pregnancy represent a population that may have 
previously had decreased access to routine HIV testing 
and/or a low perception of risk. Routine screening 
during prenatal care reduces mother-to-child transmis-
sion7 and, when combined with a partner referral and 
notification program,8 may provide opportunities to 
reach disenfranchised partners and decrease delayed 
diagnoses. 
Currently, the Centers for Disease Control and 
Prevention (CDC) provides separate guidance for 
HIV testing, counseling, and referral in the U.S., 
including testing of pregnant women9 and partner 
referral services.10 Previous research has examined 
routine testing of pregnant women11–15 and reported 
on partner notification programs,16–19 but no studies 
have examined the combined efforts of both CDC 
recommendations. Using statewide HIV records on 
young women newly diagnosed with HIV in North 
Carolina (NC), we examined the combined effect of 
NC’s testing and referral services programs on young 
women and their partners.
METHODS
As part of an ongoing investigation of HIV in young 
adults in NC,20–23 we conducted a retrospective review of 
available state HIV epidemiologic records on all women 
aged 18–30 years with newly diagnosed HIV infection 
in NC between 2002 and 2005. Data were abstracted 
from partner counseling and referral services (PCRS) 
records. PCRS counselors, also called disease inter-
vention specialists (DISs), conduct voluntary, post-
diagnosis interviews with all individuals with reported 
cases of HIV and syphilis (index cases). 
During the interview, the PCRS counselor conducts 
a risk assessment, provides risk reduction information, 
and makes referrals for medical care and case manage-
ment. Additionally, the PCRS counselor reviews com-
municable disease control measures that document the 
legal requirement to notify past partners. The PCRS 
counselor elicits names and locating information on 
all sex and needle-sharing partners (contacts), working 
with the index patient to conduct partner notification. 
All contacts to the index case are informed of possible 
exposure and offered both HIV and syphilis testing, 
either in a clinic or in the field. All information on 
both the index case and contacts is documented in 
STD*MIS, a CDC standardized electronic database, 
and in hard copy paper charts stored in secure loca-
tions across the state. Data recorded on the index case 
include demographics, risk behaviors, lab results, and 
testing history. The PCRS counselor follows up with all 
contacts and documents test uptake and results. 
A review of NC’s PCRS program in 2001 indicated 
that nearly 90% of all new cases of HIV were inter-
viewed by a PCRS counselor. The proportion of patients 
not able to be located did not vary by age or race/
ethnicity, although patients tested in a public clinic 
were more likely to be located. Approximately 87% 
of contacts identified were located, and 64% of those 
not already diagnosed with HIV were tested following 
notification.17
Using a case abstraction form, trained research assis-
tants abstracted data from the standardized fields, as 
well as the narrative sections of the PCRS case reports. 
Data were entered into a Microsoft® Access database.24 
Using unadjusted prevalence ratios (PRs) and 95% 
confidence intervals (CIs), we identified characteristics 
of women diagnosed while pregnant to determine an 
at-risk population that could be targeted for increased 
HIV screening. We examined women’s demographics 
(e.g., age and race/ethnicity), testing history, stage at 
diagnosis, and risk behaviors for associations with a 
concurrent HIV diagnosis and pregnancy. We defined 
a recent/acute diagnosis as either (1) a reactive test 
with a documented negative test in the last six months 
or (2) a ribonucleic acid (RNA) positive test with a 
concurrent antibody negative test. We defined late 
diagnosis as an acquired immunodeficiency syndrome 
(AIDS) diagnosis at first HIV test. Risk factors included 
number of sex partners, sex partner characteristics, 
and drug use. We classified the latter as use of any 
recreational drug (not including alcohol use only) and 
injection drug use (IDU). 
We described results of partner notification efforts 
including testing uptake by contacts and percent 
positivity of those testing. After linking contacts to the 
female index cases, we examined timing and stage of 
diagnosis of HIV-positive partners, testing to see if there 
were differences by pregnancy status of the female 
index case. To account for non-independence of male 
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cases (nine men were named as positive partners to 
multiple women), we used clustered regression analysis 
when testing for statistical differences. We conducted 
data analyses using SAS® software version 9.1.25
This study was approved by the University of North 
Carolina at Chapel Hill Nursing-Public Health Institu-
tional Review Board. 
RESULTS
During the four-year period, 551 women aged 18 to 
30 years with available PCRS records were newly diag-
nosed with HIV in NC; 166 (30.1%) were diagnosed 
while pregnant (Table 1). Women who reported 
exchanging sex for drugs/money (PR50.55, 95% CI 
0.30, 1.01) or using recreational drugs not including 
alcohol (PR50.72, 95% CI 0.43, 0.96) were less likely 
to be pregnant at the time of HIV diagnosis. Women 
who were co-diagnosed with HIV and AIDS were less 
likely to also be pregnant at the time of diagnosis 
(PR50.55, 95% CI 0.28, 1.09). Hispanic women were 
more likely to be diagnosed while pregnant (PR51.58, 
95% CI 1.15, 2.17). Only 11.5% of Hispanic pregnant 
women reported a previous HIV test compared with 
30.0% of non-Hispanic pregnant women (p50.05) 
(data not shown). 
Nine hundred and forty sexual partners were named 
during PCRS counseling. On average, pregnant and 
nonpregnant women reported similar numbers of 
sexual contacts during partner notification (mean51.8, 
standard deviation [SD] 5 1.6; mean = 1.7, SD51.6, 
respectively; p50.4). Similarly, we found no statisti-
cal differences in the percentage of partners located 
by pregnancy status of the index case (Figure). We 
identified 196 HIV-positive male partners with either 
previously known infections or new diagnoses. Nine 
of the infected men (previously and newly diagnosed) 
were named as partners to multiple women. Six men 
were each contacts to two women, and three men were 
each contacts to three women for a total of 21 women 
involved (3.8% of the total population of women). Nine 
of the 21 women were pregnant (5.4% of the pregnant 
population). There were no differences in prevalence 
of infected partners found through contact tracing 
by pregnancy status; 32.5% of nonpregnant women 
(n554) and 36.6% of pregnant women (n5141) had 
infected partners. However, pregnant women were 
more likely to have undiagnosed partners compared 
with nonpregnant women; 30 men newly diagnosed 
after contact tracing (14.0% of partners located) 
vs. 38 men (8.4% of partners located), respectively 
(p,0.01). 
Comparing dates of diagnosis, more than half of 
pregnant women were diagnosed prior to their partner 
compared with 22.0% of nonpregnant women (p,0.01) 
(Table 2). When women were diagnosed first, HIV-
positive contacts of pregnant women were subsequently 
diagnosed more quickly compared with nonpregnant 
women. Partners of pregnant women were diagnosed 
a mean of 63 days following the index female case’s 
reactive test (interquartile range [IQR] 22, 98) vs. a 
mean of 122 days (IQR 23, 142) for partners of non-
pregnant women (p50.07). Among all women in the 
cohort, when men were diagnosed first, they had been 
notified of their infection a mean of 1,240 days (3.4 
years) (IQR 60, 2,324) prior to the female’s diagnosis. 
There was no difference in length of time before the 
women’s diagnosis by pregnancy status.
Among all women in the cohort, when women 
were diagnosed first and their positive male partner 
was diagnosed through contact tracing, more than 
75.0% of infected partners had never been tested and 
13.3% already had progressed to an AIDS diagnosis. 
There were no statistical differences in partner’s stage 
at diagnosis or testing history by pregnancy status of 
female index case. 
DISCUSSION
We used statewide data abstracted from PCRS charts 
to examine characteristics of women newly diagnosed 
with HIV in NC, documenting differences in patient 
characteristics by pregnancy status at time of diagnosis. 
Women diagnosed with HIV during pregnancy did 
not report typical risk factors, such as drug use and 
high-risk sexual behavior. This finding suggests that 
there are few identifiable screening predictors, and 
lends support to universal HIV testing during prenatal 
care. Additionally, it underscores the need for testing 
at routine health-care visits prior to pregnancy care. 
Women who were diagnosed while pregnant were less 
likely to have progressed HIV disease (indicated by 
an AIDS diagnosis at the time of testing), suggesting 
that routine testing can help identify infections at an 
early stage.
Ethnic differences in co-diagnosis of pregnancy 
and HIV and in previous testing history suggest young 
Hispanic women may not be routinely accessing testing 
outside of prenatal care. Barriers may include low-risk 
perception,26 perceived stigma, fatalistic beliefs,27 lack 
of knowledge about treatment availability,28 and diffi-
culty accessing services.29 However, these barriers are 
likely context-specific and may depend on local clinic 
characteristics (e.g., availability of translators) and on 
the prevalence of local prevention and outreach testing 
programs. Formative research should be undertaken 
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Table 1. Characteristics of women aged 18 to 30 years with newly diagnosed HIV infection  
by pregnancy status at time of diagnosis, North Carolina, 2002–2005
Characteristics N Percent pregnant Prevalence ratio (95% CI)
Total 551 30.1
Demographics
 Age (in years)
  26–30 245 25.7 0.76 (0.58, 0.99)
  18–25 306 33.7 1.0
 Race
  White 124 31.5 1.05 (0.78, 1.41)
  Other 20 20.0 0.67 (0.27, 1.62)
  Black 406 30.0 1.0
 Ethnicity
  Hispanic 58 44.8 1.58 (1.15, 2.17)
  Non-Hispanic 493 28.4 1.0
Testing and diagnosis
 HIV stage at diagnosis 
  Recent/acute 29 24.1 0.77 (0.40, 1.49)
  AIDS 44 20.5 0.65 (0.36, 1.18)
  Chronic 478 31.4 1.0
 Previous test
  Yes 134 33.6 1.07 (0.80, 1.42)
  Unknown 96 31.3 0.99 (0.71, 1.39)
  No 321 31.5 1.0 
 Late diagnosisa
  Yes 41 17.1 0.55 (0.28, 1.09)
  No 510 31.1 1.0
Reported risk factors
 Exchanged sex for drugs/money
  Yes 52 17.3 0.55 (0.30, 1.01)
  No 499 31.5 1.0
 Used recreational drugsb
  Yes 195 24.1 0.72 (0.43, 0.96)
  No 356 33.4 1.0
 Injection drug use
  Yes 14 21.4 0.71 (0.26, 1.94)
  No 537 30.4 1.0
Partner characteristics
 Sex with injection drug user 
  Yes 16 18.8 0.62 (0.22, 1.72)
  No 535 30.5 1.0
 Sex with bisexual man
  Yes 10 50.0 1.68 (0.89, 3.16)
  No 541 29.8 1.0
 Sex with HIV1 partner
  Yes 34 32.4 1.08 (0.65, 1.79)
  No 517 30.0 1.0
aAIDS diagnosis at first HIV test
bNot including alcohol use only 
HIV 5 human immunodeficiency virus
CI 5 confidence interval
AIDS 5 acquired immunodeficiency syndrome
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prior to intervention development. Qualitative meth-
ods, including focus groups and in-depth interviews, 
have been used to identify barriers to other HIV pre-
vention efforts30–32 and may be useful in developing 
targeted testing programs.
By linking abstracted data on the female index cases 
to their sexual partners, we also examined the effects 
of the PCRS partner notification efforts. In this sample, 
contact tracing and notification identified undiagnosed 
infections in male partners, including many cases that 
reported no previous testing and were in the late stages 
of disease (i.e., AIDS). Although there were no differ-
ences in the stage of the partner’s diagnosis, pregnant 
women were more likely to have undiagnosed, positive 
partners than nonpregnant women. This finding sug-
gests that the combination of comprehensive prenatal 
screening with partner notification can be effective in 
reaching infected individuals who are undiagnosed. 
However, among all women, the majority of positive 
male partners were told of their infection prior to the 
woman’s diagnosis. It is unclear if the prolonged time 
lag between diagnoses was a result of men’s undisclosed 
status to female partners or their partner’s acceptance 
of risk and/or decision not to test following initial 
partner notification. This finding highlights the need 
to understand both testing practices and post-diagnosis 
risk behaviors, as well as create opportunities for pre-
vention with positives, such as clinic-based interven-
tions,33 prevention case management,34 and group-level 
interventions.35 
Limitations
We made efficient use of routinely collected statewide 
data on newly infected women; however, this analysis 
had several limitations. We included only charts of 
index patients who were able to be contacted and 
interviewed. Although close to 90% of new cases of 
HIV are located by PCRS counselors,17 it is likely that 
the cases not interviewed were not missing at random 
(e.g., may be more likely to be ill, to have left the state, 
or to have provided false contacting information). We 
were unable to assess this bias, but the low prevalence 
of cases that were not interviewed should have minimal 
impact on the analysis. 
Additionally, approximately 30% of named sexual 
partners were unable to be located and interviewed 
by PCRS counselors. This percentage is higher than 
the prevalence reported in the 2001 review of the NC 
PCRS program. The difference may be due to our 
restriction to only females or our chart abstraction 
protocols. For our data, we included all named con-
tacts, including those who were unlikely to be located 
Figure. Outcomes of partner notification services for 18- to 30-year-old female index cases newly diagnosed 
between 2002 and 2005 in North Carolina, stratified by pregnancy status at time of human immunodeficency 
virus diagnosis
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(e.g., were residing out of the state or country or for 
whom no contacting information was provided). Still, 
30% missing data could have substantial impact on our 
conclusions. However, there were no differences in the 
proportion of contacts interviewed by pregnancy status 
of the female index case, thereby minimizing bias in 
the statistical comparisons. 
The majority of data abstracted from the PCRS 
charts were based on self-report, including risk behav-
iors and named sexual contacts. Pregnant women may 
differentially report risk behaviors, such as drug use 
and number of sexual partners, due to social desir-
ability bias. Additionally, we did not have information 
on the type of sexual partnerships (e.g., husband, 
casual partner) for the named contacts. Because 
pregnant women may have a higher prevalence of 
steady partnerships, this may explain the shorter time 
lag between subsequent diagnoses of infected undiag-
nosed partners (e.g., they are easier to locate and/or 
more willing to accept testing). Additionally, for men 
who knew they were infected, partner type may have 
influenced whether they disclosed their status to the 
female case. Future research could investigate the role 
of partner type in outcomes of PCRS to better inform 
prevention efforts. 
Finally, PCRS counselors were not able to identify an 
infected sex partner for more than 60% of the female 
cases in this sample. This lack of identification may 
be the result of missing data on partners unable to 
be located, partners declining testing, or women who 
may not have provided complete information on their 
sexual partners during PCRS counseling. 
CONCLUSIONS
Our review of testing and PCRS for pregnant women 
documented the public health impact of the combined 
programs. Our findings suggest that comprehensive 
testing during prenatal care may increase early diagno-
sis of HIV among females and, combined with partner 
notification, can be effective in reaching infected male 
partners who are undiagnosed. At the community level, 
monitoring trends in co-diagnosis of pregnancy and 
HIV can aid public health practitioners in identifying 
groups to be targeted for increased screening efforts, 
as well as subpopulations that may have differential 
access to and acceptance of routine HIV screening. In 
this study sample, Hispanic women were disproportion-
ately diagnosed while pregnant; however, other settings 
may have populations with different demographic or 
risk profiles. 
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